Codetta Bio introduced the Concerto platform at AACR in 2025 and initially made the technology available through a service-based Technology Access Program (TAP). Following strong customer engagement ...

Codetta Bio™, a leader in multi-omic solutions that combine ultrasensitive protein quantification with simultaneous RNA and DNA analysis, today announced major product and commercialization milestones ...

ORLANDO, Fla., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Codetta Bio™, a leader in multi-omic solutions that combine ultrasensitive protein quantification with simultaneous RNA and DNA analysis, today ...

(MENAFN- GlobeNewsWire - Nasdaq) ORLANDO, Fla., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Codetta BioTM, a leader in multi-omic solutions that combine ultrasensitive protein quantification with simultaneous ...